Latest Breaking News On - Sath shukla - Page 1 : comparemela.com

Spero Therapeutics To Participate In H C Wainwright Annual Bioconnect Investor Conference

Spero Therapeutics To Participate In H C Wainwright Annual Bioconnect Investor Conference
menafn.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from menafn.com Daily Mail and Mail on Sunday newspapers.

United kingdomNew yorkUnited statesSath shuklaSpero therapeutics incChief executive officerSpero therapeuticsAnnual bioconnect investor conferenceHeadquarters new york

Spero Therapeutics Announces First Quarter 2024 Operating Results and Provides a Business Update

Spero Therapeutics Announces First Quarter 2024 Operating Results and Provides a Business Update
tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.

United kingdomUnited statesAshleyr robinsonSath shuklaDepartment of healthWarfighter medical research program under award noNational institute of allergyDepartment of the armyBiomedical advanced researchDepartment of defenseLifesci advisorsSpero therapeutics incAdministration for strategic preparednessOffice of theHuman servicesDrug administration

Spero Therapeutics (SPRO) Provides Corporate Update and 2024 Outlook

Spero Therapeutics (SPRO) Provides Corporate Update and 2024 Outlook
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United kingdomUnited statesSath shuklaBiomedical advanced researchTebipenem hbr researchSpero therapeutics incDevelopment authorityWarfighter medical research program under award noNational institute of allergyOffice of theHealth affairsAdministration for strategic preparednessGovernment agency researchDepartment of defenseUs department of healthDepartment of health

Spero Therapeutics Provides Corporate Update and 2024

In 2H 2024, expect to provide Phase 2a topline proof-of-concept data from our wholly-owned lead program SPR720 in NTM-PD patients Initiated dosing in.

United kingdomUnited statesLora grassilliTed jenkinsSath shuklaNational institutes of healthExchange commissionBiomedical advanced researchTebipenem hbr researchWarfighter medical research program under award noGovernment agency researchDevelopment authorityHuman servicesDepartment of defenseOffice of theAdministration for strategic preparedness

Spero Therapeutics Announces First Patient, First Visit for Phase 3 PIVOT-PO Trial Evaluating Tebipenem HBr in Complicated Urinary Tract Infections

Spero Therapeutics Announces First Patient, First Visit for Phase 3 PIVOT-PO Trial Evaluating Tebipenem HBr in Complicated Urinary Tract Infections
tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.

United statesUnited kingdomLora grassilliTed jenkinsSath shuklaExchange commissionAdministration for strategic preparednessHealth media relationsDevelopment authorityMeiji seika pharma coUs department of healthTebipenem hbr researchHuman servicesBiomedical advanced researchDrug administrationZeno group